| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.24 | 3e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |